Page 18 - 88_01

HOXB8 mRNA. Science 304, 594-596 (2004).
37. R. S. Pillai et al., Inhibition of translational initiation by let-7 Mi-
croRNA in human cells. Science 309, 1573-1576 (2005).
38. P. H. Olsen, V. Ambros, The lin-4 regulatory RNA controls develop-
mental timing in Caenorhabditis elegans by blocking LIN-14 protein
synthesis after the initiation of translation. Dev Biol 216, 671-680
(1999).
43. S. R. Viswanathan, G. Q. Daley, R. I. Gregory, Selective blockade of
microRNA processing by Lin28. Science 320, 97-100 (2008).
44. S. Bagga et al., Regulation by let-7 and lin-4 miRNAs results in
target mRNA degradation. Cell 122, 553-563 (2005).
45. P. P. Medina, F. J. Slack, microRNAs and cancer: an overview. Cell
Cycle 7, 2485-2492 (2008).
46. A. Stark, J. Brennecke, N. Bushati, R. B. Russell, S. M. Cohen, Ani-
mal MicroRNAs confer robustness to gene expression and have a
significant impact on 3'UTR evolution. Cell 123, 1133-1146
(2005).
47. B. P. Lewis, C. B. Burge, D. P. Bartel, Conserved seed pairing, often
flanked by adenosines, indicates that thousands of human genes
are microRNA targets. Cell 120, 15-20 (2005).
48. B. John et al., Human MicroRNA targets. PLoS Biol 2, e363 (2004).
49. A. Krek et al., Combinatorial microRNA target predictions. Nat Genet
37, 495-500 (2005).
50. A. Grimson et al., MicroRNA targeting specificity in mammals: de-
terminants beyond seed pairing. Mol Cell 27, 91-105 (2007).
51. D. Hanahan, R. A. Weinberg, The hallmarks of cancer. Cell 100,
57-70 (2000).
52. N. Yanaihara et al., Unique microRNA molecular profiles in lung
cancer diagnosis and prognosis. Cancer Cell 9, 189-198 (2006).
53. J. Lu et al., MicroRNA expression profiles classify human cancers.
Nature 435, 834-838 (2005).
54. S. Volinia et al., A microRNA expression signature of human solid
tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103,
2257-2261 (2006).
55. A. Esquela-Kerscher, F. J. Slack, Oncomirs - microRNAs with a role
in cancer. Nat Rev Cancer 6, 259-269 (2006).
56. M. S. Kumar, J. Lu, K. L. Mercer, T. R. Golub, T. Jacks, Impaired mi-
croRNA processing enhances cellular transformation and tumorige-
nesis. Nat Genet 39, 673-677 (2007).
57. Y. Karube et al., Reduced expression of Dicer associated with poor
prognosis in lung cancer patients. Cancer Sci 96, 111-115 (2005).
58. E. P. Murchison, J. F. Partridge, O. H. Tam, S. Cheloufi, G. J. Hannon,
Characterization of Dicer-deficient murine embryonic stem cells. Proc
Natl Acad Sci U S A 102, 12135-12140 (2005).
59. C. Kanellopoulou et al., Dicer-deficient mouse embryonic stem cells
are defective in differentiation and centromeric silencing. Genes Dev
19, 489-501 (2005).
OncomicroRNAs and their future pharmacological applications
16 Pedro Pablo Medina Vico
An. Real Acad. Farm. Vol. 88. Nº 1 (2022) · pp.7-18
ANALES
RANF
www.analesranf.com
60. Y. Wang, R. Medvid, C. Melton, R. Jaenisch, R. Blelloch, DGCR8 is
essential for microRNA biogenesis and silencing of embryonic stem
cell self-renewal. Nat Genet 39, 380-385 (2007).
61. R. Koesters et al., Human eukaryotic initiation factor EIF2C1 gene:
cDNA sequence, genomic organization, localization to chromosomal
bands 1p34-p35, and expression. Genomics 61, 210-218 (1999).
62. A. Aravin et al., A novel class of small RNAs bind to MILI protein in
mouse testes. Nature 442, 203-207 (2006).
63. H. Taubert et al., Expression of the stem cell self-renewal gene Hiwi
and risk of tumour-related death in patients with soft-tissue sar-
coma. Oncogene 26, 1098-1100 (2007).
64. X. Liu et al., Expression of hiwi gene in human gastric cancer was
associated with proliferation of cancer cells. Int J Cancer 118, 1922-
1929 (2006).
65. D. Qiao, A. M. Zeeman, W. Deng, L. H. Looijenga, H. Lin, Molecular
characterization of hiwi, a human member of the piwi gene family
whose overexpression is correlated to seminomas. Oncogene 21,
3988-3999 (2002).
66. J. Kota et al., Therapeutic microRNA delivery suppresses tumorige-
nesis in a murine liver cancer model. Cell 137, 1005-1017 (2009).
67. A. Cimmino et al., miR-15 and miR-16 induce apoptosis by targe-
ting BCL2. Proc Natl Acad Sci U S A 102, 13944-13949 (2005).
68. S. M. Johnson et al., RAS is regulated by the let-7 microRNA family.
Cell 120, 635-647 (2005).
69. C. Mayr, M. T. Hemann, D. P. Bartel, Disrupting the pairing between
let-7 and Hmga2 enhances oncogenic transformation. Science 315,
1576-1579 (2007).
70. Y. S. Lee, A. Dutta, The tumor suppressor microRNA let-7 represses
the HMGA2 oncogene. Genes Dev 21, 1025-1030 (2007).
71. V. B. Sampson et al., MicroRNA let-7a down-regulates MYC and re-
verts MYC-induced growth in Burkitt lymphoma cells. Cancer Res
67, 9762-9770 (2007).
72. C. D. Johnson et al., The let-7 microRNA represses cell proliferation
pathways in human cells. Cancer Res 67, 7713-7722 (2007).
73. P. P. Trang* & Medina* et al., Regression of murine lung tumors by
the let-7 microRNA. Oncogene 29, 1580-1587 (2010).
74. G. T. Bommer et al., p53-mediated activation of miRNA34 candidate
tumor-suppressor genes. Curr Biol 17, 1298-1307 (2007).
75. C. Welch, Y. Chen, R. L. Stallings, MicroRNA-34a functions as a po-
tential tumor suppressor by inducing apoptosis in neuroblastoma
cells. Oncogene 26, 5017-5022 (2007).
76. H. Tazawa, N. Tsuchiya, M. Izumiya, H. Nakagama, Tumor-suppres-
sive miR-34a induces senescence-like growth arrest through mo-
dulation of the E2F pathway in human colon cancer cells. Proc Natl
Acad Sci U S A 104, 15472-15477 (2007).
77. L. He et al., A microRNA component of the p53 tumour suppressor
network. Nature 447, 1130-1134 (2007).